Cbd Financial Statements From 2010 to 2024
| CBDL Stock | USD 0.0005 0.0001 16.67% |
Check Cbd Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cbd Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cbd financial statements analysis is a perfect complement when working with Cbd Life Valuation or Volatility modules.
Cbd |
Cbd Life Sciences Company Current Valuation Analysis
Cbd Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cbd Life Current Valuation | 51.93 K |
Most of Cbd Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cbd Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cbd Life Sciences has a Current Valuation of 51.93 K. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Cbd Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cbd Life's current stock value. Our valuation model uses many indicators to compare Cbd Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cbd Life competition to find correlations between indicators driving Cbd Life's intrinsic value. More Info.Cbd Life Sciences is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cbd Life's earnings, one of the primary drivers of an investment's value.About Cbd Life Financial Statements
Cbd Life investors utilize fundamental indicators, such as revenue or net income, to predict how Cbd Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. Cbd Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cbd Pink Sheet
Cbd Life financial ratios help investors to determine whether Cbd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cbd with respect to the benefits of owning Cbd Life security.